Avinger, Inc. Appoints Jaafer Golzar Chief Medical Officer
July 10, 2018 at 08:30 am EDT
Share
Avinger, Inc. announced the appointment, effective immediately, of Jaafer Golzar, as the company’s Chief Medical Officer. Dr. Golzar provides Avinger with an extensive and impressive history of clinical leadership within the endovascular field. Dr. Golzar is a practicing interventional cardiologist with Advocate Medical Group in Chicago. He is the Director of Limb Salvage and Endovascular Intervention at Advocate Trinity Hospital. Dr. Golzar is also a leading educator on interventional techniques and technologies and is the founder and previous director of the Chicago Endovascular Conference (CVC), an international-scale annual conference designed to address the educational needs of physicians and other health care professionals treating patients with peripheral arterial and venous diseases. Prior to joining Avinger, Dr. Golzar was also Medical Director – Interventional Vascular for BTG International.
Avinger, Inc. is a commercial-stage medical device company. The Company designs, manufactures, and sells real-time, image-guided, minimally invasive catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). Its Lumivascular platform includes the Lightbox real-time imaging console, the Ocelot and Tigereye family of catheters, which are image-guided catheters designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO), and the Pantheris family of catheters, its image-guided atherectomy family of catheters designed to allow physicians to remove arterial plaque in PAD patients. Its Pantheris is a single-use product and provides physicians with the ability to see a cross-sectional view of the peripheral artery to guide the removal of blockages throughout the procedure. It has also developed a line extension of its Pantheris image-guided atherectomy platform, Pantheris Small Vessel (SV).
AVINGER, INC. 
